Page last updated: 2024-08-17

ampicillin and End Stage Liver Disease

ampicillin has been researched along with End Stage Liver Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, T; Carpenter, I; Eguchi, S; Hara, T; Hidaka, M; Kinoshita, A; Kitasato, A; Kuroki, T; Soyama, A; Takatsuki, M1
Hoyer, DP; Juntermanns, B; Kaiser, GM; Manka, P; Mathé, Z; Pracht, W; Radunz, S; Rath, PM; Schulze, M; Steinmann, J; Treckmann, JW1

Other Studies

2 other study(ies) available for ampicillin and End Stage Liver Disease

ArticleYear
The impact of treated bacterial infections within one month before living donor liver transplantation in adults.
    Annals of transplantation, 2014, Dec-23, Volume: 19

    Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Drug Therapy, Combination; End Stage Liver Disease; Female; Humans; Incidence; Liver Transplantation; Living Donors; Male; Middle Aged; Perioperative Care; Postoperative Complications; Preoperative Period; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome

2014
Infectious complications in the era of MELD.
    Annals of transplantation, 2015, May-28, Volume: 20

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; End Stage Liver Disease; Female; Graft Survival; Humans; Incidence; Liver Transplantation; Male; Middle Aged; Pneumonia; Retrospective Studies; Sepsis; Severity of Illness Index; Sulbactam; Treatment Outcome

2015